Medplus Health

MEDPLUS03 May 2024

Retail

₹

-15.00 (-2.20%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Medplus Health

Medplus Health

Retail

MEDPLUS03 May 2024

₹

-15.00 (-2.20%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
30-Mar-2024	BC	Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Standalone and Consolidated	28-May-2024
16-Feb-2024	BC	Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2024 inter alia to consider and approve to discuss the management recommend	21-Feb-2024
17-Feb-2024	BC	Source: BSE Announcement PDF	17-Feb-2024
17-Feb-2024	BC	Source: BSE Announcement PDF The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 23, 20	16-Feb-2024
12-Feb-2024	BC	Source: BSE Anouncement PDF	09-Feb-2024

No Rights has been declared by MEDPLUS

Book Closure

Record Date	Split Date	Purpose
28-May-2024	-	Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Standalone and Consolidated
21-Feb-2024	-	Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2024 inter alia to consider and approve to discuss the management recommend
17-Feb-2024	01 Jan'1900	Source: BSE Announcement PDF
16-Feb-2024	01 Jan'1900	Source: BSE Announcement PDF The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 23, 20
09-Feb-2024	01 Jan'1900	Source: BSE Anouncement PDF

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Medplus Health Services Ltd ₹667.50(-15.00/-2.20%)	667.50	-15.00	7,979.09	-7.34	0.00	6.94
Salora International Ltd ₹64.50(-0.77/-1.18%)	64.50	-0.77	56.82	99.94	0.00	1.00
Saptak Chem & Business Ltd ₹3.55(0.00/0.00%)	3.55	+0.00	3.81	18.33	0.00	-1.78
Future Enterprises Ltd ₹0.73(0.00/0.00%)	0.73	+0.00	52.42	12.31	0.00	-0.08
Credo Brands Marketing Ltd ₹186.20(-0.20/-0.11%)	186.20	-0.20	1,200.64	0.00	16.29	3.78
Hindware Home Innovation Ltd ₹350.25(-2.50/-0.71%)	350.25	-2.50	2,532.18	-7.52	0.00	20.25

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	148.10	98.67	71.89	86.95	57.24	42.45
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	148.10	98.67	71.89	86.95	57.24	42.45
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.82	1.77	1.81	2.54	4.07	4.27
Total Income	149.92	100.44	73.70	89.49	61.31	46.72
Total Expenditure	137.31	92.40	69.57	75.53	53.50	42.88
PBIDT	12.61	8.04	4.13	13.96	7.81	3.84
Interest	2.10	2.11	2.08	2.05	1.79	1.46
PBDT	10.51	5.93	2.05	11.91	6.02	2.38
Depreciation	6.27	5.97	5.54	5.33	4.24	3.20
Tax	1.05	0.00	0.00	0.88	1.16	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	3.19	-0.04	-3.49	5.71	0.62	-0.82
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	3.19	-0.04	-3.49	5.71	0.62	-0.82

EPS (Unit Curr.)	0.27	0.05	-0.29	0.15	0.15	-0.07
EPS (Adj) (Unit Curr.)	0.27	0.05	-0.29	0.15	0.15	-0.07
Calculated EPS (Unit Curr.)	0.27	0.00	-0.29	0.48	0.05	-0.07
Calculated EPS (Adj) (Unit Curr.)	0.27	0.00	-0.29	0.48	0.05	-0.07
Calculated EPS (Ann.) (Unit Curr.)	1.07	-0.01	-1.17	1.91	0.21	-0.27
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.07	-0.01	-1.17	1.91	0.21	-0.27
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	23.91	23.87	23.86	23.86	23.86	23.86
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	8.51	8.15	5.74	16.06	13.64	9.05
PBDTM(%)	7.10	6.01	2.85	13.70	10.52	5.61
PATM(%)	2.15	-0.04	-4.85	6.57	1.08	-1.93

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	1441.47	1408.59	1284.30	1252.98	1190.31	1120.63
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1441.47	1408.59	1284.30	1252.98	1190.31	1120.63
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	9.79	10.37	9.39	13.69	11.36	10.89
Total Income	1451.26	1418.95	1293.69	1266.68	1201.68	1131.52
Total Expenditure	1349.69	1323.50	1212.95	1171.35	1118.59	1060.96
PBIDT	101.57	95.46	80.74	95.32	83.08	70.56
Interest	24.50	23.54	23.27	22.27	21.08	19.87
PBDT	77.07	71.92	57.47	73.05	62.00	50.69
Depreciation	57.11	55.47	52.42	55.80	45.79	41.87
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	9.78	5.72	2.93	9.48	5.05	2.43
Deferred Tax	-3.52	-3.82	-1.64	-18.78	-2.22	-0.08
Reported Profit After Tax	13.71	14.54	3.77	26.56	13.38	6.48
Minority Interest After NP	-0.02	-0.02	-0.02	-0.02	-0.03	-0.09
Net Profit after Minority Interest	13.73	14.56	3.79	26.58	13.41	6.57

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	13.73	14.56	3.79	26.58	13.41	6.57

EPS (Unit Curr.)	1.15	1.22	0.32	2.24	1.12	0.55
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	23.91	23.87	23.86	23.86	23.86	23.86

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	7.05	6.78	6.29	7.61	6.98	6.30
PBDTM(%)	5.35	5.11	4.47	5.83	5.21	4.52
PATM(%)	0.95	1.03	0.29	2.12	1.12	0.58

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	23.86	23.86	0.45	0.19	0.19	0.19
Reserves Total	1117.42	1088.92	146.23	395.41	185.01	185.01
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	370.81	0.00	0.00	0.00
Total Shareholders Funds	1141.28	1112.78	517.49	395.60	185.20	185.20
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	85.80	44.42	7.31	2.56	0.00	0.00
Total Debt	85.80	44.42	7.31	2.56	0.00	0.00
Total Liabilities	1227.08	1157.20	524.80	398.16	185.20	185.20
APPLICATION OF FUNDS :
Gross Block	190.35	88.58	25.00	8.83	1.33	2.03
Less : Accumulated Depreciation	10.93	3.56	2.32	1.66	1.19	1.77
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	179.42	85.02	22.68	7.17	0.14	0.26
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	17.91	15.52	2.01	0.95	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	917.16	418.45	408.50	381.09	186.03	180.72
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	6.69	3.90	4.79	3.94	0.23	0.15
Sundry Debtors	37.61	21.29	11.51	8.60	2.08	0.56
Cash and Bank	90.16	7.44	86.68	10.74	0.53	4.28
Loans and Advances	16.12	624.71	3.52	1.63	0.09	0.13
Total Current Assets	150.58	657.34	106.49	24.90	2.93	5.11
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	41.99	28.81	22.10	15.50	5.90	3.07
Provisions	1.03	0.74	0.66	0.45	0.27	0.26
Total Current Liabilities	43.03	29.54	22.76	15.95	6.17	3.34
Net Current Assets	107.56	627.80	83.73	8.95	-3.24	1.77
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	1222.04	1146.79	516.91	398.16	182.94	182.75
Contingent Liabilities	0.00	0.00	185.00	177.50	0.00	113.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	23.86	23.86	0.45	0.19	0.19	0.19
Reserves Total	1467.32	1393.91	359.30	527.61	291.14	303.27
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	370.81	0.00	0.00	0.00
Total Shareholders Funds	1491.18	1417.77	730.56	527.80	291.33	303.46
Minority Interest	-0.68	-0.52	0.55	1.30	0.02	0.02
Secured Loans	0.00	142.68	135.24	105.05	71.90	0.00
Unsecured Loans	899.92	672.25	454.98	372.24	356.65	162.36
Total Debt	899.92	814.93	590.22	477.29	428.55	162.36
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	28.45	21.29	19.51	19.17	10.75	7.44
Total Liabilities	2418.87	2253.47	1340.84	1025.56	730.65	473.28
APPLICATION OF FUNDS :
Gross Block	1301.76	920.12	617.57	502.78	446.40	141.53
Less: Accumulated Depreciation	163.80	121.39	100.27	83.32	69.02	58.05
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1137.96	798.73	517.30	419.46	377.38	83.48
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	25.47	20.45	5.54	4.94	1.43	0.93
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.03	0.03	0.03	0.25	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1144.09	914.98	749.96	643.56	394.07	363.25
Sundry Debtors	8.65	6.04	5.37	6.40	8.75	10.32
Cash and Bank	283.84	34.41	118.60	140.69	49.91	58.05
Loans and Advances	44.12	676.25	49.12	24.87	17.01	25.90
Total Current Assets	1480.69	1631.67	923.04	815.52	469.74	457.52
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	350.75	318.77	204.61	303.60	215.69	163.61
Provisions	27.09	21.80	20.21	19.54	12.34	7.50
Total Current Liabilities	377.84	340.57	224.82	323.14	228.03	171.11
Net Current Assets	1102.85	1291.10	698.22	492.38	241.71	286.41
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	65.81	44.95	38.61	40.16	49.85	34.70
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.03	0.00
Net Deferred Tax	65.81	44.95	38.61	40.16	49.82	34.70
Other Assets	86.75	98.22	81.13	68.37	60.31	67.77
Total Assets
Contingent Liabilities	11.89	11.89	12.00	47.64	30.17	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.94	86.68	10.74	0.53	4.28
Net Cash from Operating Activities	11.41	-18.37	-6.24	2.89	-0.93
Net Cash Used In Investing Activities	31.72	-635.99	-14.77	-196.64	-2.81
Net Cash Used In Financing Activities	-8.36	568.63	96.94	203.96	0.00
Net Inc./Dec In Cash And Cash Equivalents	34.77	-85.74	75.94	10.21	-3.74
Cash And Cash Equivalents At End Of The Year	35.70	0.94	86.68	10.74	0.53

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

40.39%

FII Shareholding

14.94%

DII Shareholding

22.47%

Public Shareholding

22.10%

**Promoter pledged shareholding 40.39%

About Medplus Health Services Ltd

Medplus Health Services Ltd is in the Retail sector, having a market capitalization of Rs. 7979.09 crores. It has reported a sales of Rs. 148.1 crores and a net profit of Rs. 3.19 crores for the quarter ended December 2018. The company management includes GANGADI MADHUKAR REDDY, GANGADI MADHUKAR REDDY,Anish Saraf,Atul Gupta,Murali Sivaraman,Madhavan Ganesan,Hiroo Mirchandani,Manoj Kumar Srivastava (Medplus Health Services Ltd) among others.

Chairman

GANGADI MADHUKAR REDDY

Registered office

707 7th Floor 5-9-13 Saifabad,Taramandal Commercial Complex,Hyderabad,Telangana,500004

FAX :

Background

Incorporation Year2006

Face Value₹2

Market Lot1

How to buy Medplus Health shares on nse?

To buy Medplus Health shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Medplus Health share price today?

The Medplus Health shares price on nse is Rs.667.5 today.

What is the market cap of Medplus Health shares on BSE ?

The company has a market capitalization of Rs.7979.09Cr

What is the PE & PB ratio of Medplus Health shares ?

PE is 0 and PB is 6.94

What is the 52 Week High and Low of Medplus Health shares?

Medplus Health stock price high: Rs.977.45 Medplus Health stock price low: Rs.597.95